Working in partnership to advance the 3Rs in toxicity testing.
Toxicological assessment of pharmaceutical and non-pharmaceutical chemicals is a regulatory requirement to ensure all compounds likely to be exposed to humans or the environment are safe. These studies rely on the use of large numbers of animals and involve a number of assumptions and extrapolations that remain controversial in assuring consumer safety. The UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) has taken a collaborative approach to identify opportunities for implementation of the 3Rs principles (Replacement, Reduction and Refinement) to drive innovation and support animal welfare in toxicity testing. This review highlights the mechanisms by which the NC3Rs is working with the pharmaceutical and chemical industries and regulatory authorities to achieve these goals.
Holmes
Anthony M
AM
National Centre for the Replacement, Refinement and Reduction of Animals in Research, 20 Park Crescent, London W1B1AL, UK. anthony.holmes@nc3rs.org.uk
Creton
Stuart
S
Chapman
Kathryn
K
D032761:Animal Experimentation; D000822:Animal Husbandry / Q000592:standards; D000826:Animal Testing Alternatives / Q000379:methods*; D000827:Animal Welfare / Q000592:standards; D003299:Cooperative Behavior; D004345:Drug Industry / Q000592:standards; D055818:Public-Private Sector Partnerships; D018675:Toxicity Tests / Q000379:methods / Q000592:standards*